Please enable JavaScript.
Coggle requires JavaScript to display documents.
Ovarian Cancer - Coggle Diagram
Ovarian Cancer
-
Common Findings
-
Abdominal distention or ascites (Danhausen et al., 2019)
Loss of apetite (Danhausen et al., 2019)
Pelvic pain (Danhausen et al., 2019)
-
-
-
When metastasized can cause pleural effusion (Danhausen et al., 2019)
Diagnostic Tests
Ultrasound imaging (Li, 2019; Danhausen et al., 2019)
Serum biomarker testing (Li, 2019; Danhausen et al., 2019)
CA-125 testing, a protein that is expressed in epithelial tissues, 90% of women with metastatic ovarian cancer have elevated serum levels (Li, 2019.)
Human epididymis protein 4, or HE4is a protease inhibitor that is expressed by malignant ovarian cells and can be found in blood serum (Li, 2019)
AFP, alpha-fetoprotein (Danhausen et al., 2019
Beta-human choionic growth hormone (HCG) (Danhausen et al., 2019
Gynecological assessment (Danhausen et al., 2019)
-
-
-
Treatments
Initial approach is surgery to remove tumor and stage the cancer (Danhausen et al., 2019)
-
-
Incidence
Fifth Leading cause of cancer related death among women (Penny, 2020).
Accounts for 21% of all gynecologic cancers (Danhausen et al., 2019).
Chances that a woman develops ovarian cancer in her lifetime is 1 in 70 (Penny, 2020).
-
-
-